ZA200105702B - Antiviral nucleoside analogues. - Google Patents

Antiviral nucleoside analogues. Download PDF

Info

Publication number
ZA200105702B
ZA200105702B ZA200105702A ZA200105702A ZA200105702B ZA 200105702 B ZA200105702 B ZA 200105702B ZA 200105702 A ZA200105702 A ZA 200105702A ZA 200105702 A ZA200105702 A ZA 200105702A ZA 200105702 B ZA200105702 B ZA 200105702B
Authority
ZA
South Africa
Prior art keywords
compound
compound according
nucleoside
treatment
alkyl
Prior art date
Application number
ZA200105702A
Other languages
English (en)
Inventor
Nghe Nguyen-Ba
Original Assignee
Shire Biochem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Biochem Inc filed Critical Shire Biochem Inc
Publication of ZA200105702B publication Critical patent/ZA200105702B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200105702A 1998-12-23 2001-07-11 Antiviral nucleoside analogues. ZA200105702B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11379798P 1998-12-23 1998-12-23

Publications (1)

Publication Number Publication Date
ZA200105702B true ZA200105702B (en) 2002-10-11

Family

ID=22351590

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200105702A ZA200105702B (en) 1998-12-23 2001-07-11 Antiviral nucleoside analogues.

Country Status (27)

Country Link
US (3) US6358963B1 (cg-RX-API-DMAC7.html)
EP (1) EP1140937B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002533470A (cg-RX-API-DMAC7.html)
KR (1) KR100653485B1 (cg-RX-API-DMAC7.html)
CN (1) CN1117751C (cg-RX-API-DMAC7.html)
AP (1) AP2001002207A0 (cg-RX-API-DMAC7.html)
AT (1) ATE254126T1 (cg-RX-API-DMAC7.html)
AU (1) AU760875B2 (cg-RX-API-DMAC7.html)
BR (1) BR9916849A (cg-RX-API-DMAC7.html)
CA (1) CA2355712C (cg-RX-API-DMAC7.html)
CZ (1) CZ20012352A3 (cg-RX-API-DMAC7.html)
DE (1) DE69912842T2 (cg-RX-API-DMAC7.html)
DK (1) DK1140937T3 (cg-RX-API-DMAC7.html)
EA (1) EA004767B1 (cg-RX-API-DMAC7.html)
ES (1) ES2209532T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0104827A3 (cg-RX-API-DMAC7.html)
ID (1) ID30477A (cg-RX-API-DMAC7.html)
IL (1) IL143867A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA01006425A (cg-RX-API-DMAC7.html)
NO (1) NO20013163L (cg-RX-API-DMAC7.html)
NZ (1) NZ513094A (cg-RX-API-DMAC7.html)
OA (1) OA11741A (cg-RX-API-DMAC7.html)
PT (1) PT1140937E (cg-RX-API-DMAC7.html)
TR (1) TR200102501T2 (cg-RX-API-DMAC7.html)
UY (1) UY25878A1 (cg-RX-API-DMAC7.html)
WO (1) WO2000039143A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200105702B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL143867A0 (en) * 1998-12-23 2002-04-21 Shire Biochem Inc Antiviral nucleoside analogues
WO2001058894A1 (en) * 2000-02-11 2001-08-16 Shire Biochem Inc. Stereoselective synthesis of nucleoside analogues
AU2003261114A1 (en) * 2002-07-03 2004-02-09 Triangle Pharmaceuticals, Inc. Combination therapy with 1,3-dioxolanes and inosine monophosphate dehydrogenase inhibitors
MXPA05001451A (es) 2002-08-06 2005-09-30 Pharmasset Ltd Procesos para preparar nucleosidos de 1,3-dioxolano.
US7706405B2 (en) * 2002-09-12 2010-04-27 Interdigital Technology Corporation System for efficient recovery of Node-B buffered data following MAC layer reset
WO2004048590A1 (en) * 2002-11-18 2004-06-10 Shire Biochem Inc. Stereoselective process for the production of dioxolane nucleoside analogues
DE10335061B4 (de) * 2003-07-31 2005-11-17 Wacker-Chemie Gmbh Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten
KR101157468B1 (ko) 2004-02-03 2012-07-06 에모리 유니버시티 1,3-디옥솔란 뉴클레오시드 제조방법
US7322412B2 (en) * 2004-08-30 2008-01-29 Halliburton Energy Services, Inc. Casing shoes and methods of reverse-circulation cementing of casing
EP2105412B1 (de) * 2008-03-20 2011-07-13 Befesa Salzschlacke Gmbh Hochtonerdehaltiger Rohstoff und Verfahren zur Herstellung
WO2012048455A1 (zh) * 2010-10-12 2012-04-19 武汉大学 一种抗病毒透皮吸收贴片及其制备方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041037A (en) 1975-06-10 1977-08-09 American Home Products Corporation Antitumor derivatives of periodate-oxidized cytidine
US4000137A (en) 1975-06-10 1976-12-28 American Home Products Corporation Antitumor derivatives of periodate-oxidized nucleosides
JPS5668674A (en) 1979-11-08 1981-06-09 Shionogi & Co Ltd 5-fluorouracil derivative
JPS5738774A (en) 1980-08-19 1982-03-03 Chugai Pharmaceut Co Ltd Uracil derivative and its preparation
US4479942A (en) 1981-08-10 1984-10-30 Fujisawa Pharmaceutical Co., Ltd. Tetrahydrofurnancarboxylic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof
IL86007A0 (en) * 1987-04-09 1988-09-30 Wellcome Found 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
HU198933B (en) 1987-11-02 1989-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing new xanthine derivatives and pharmaceutical compositions comprising same as active ingredient
NZ228645A (en) * 1988-04-11 1991-09-25 Iaf Biochem Int 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections
US5041449A (en) 1988-04-11 1991-08-20 Iaf Biochem International, Inc. 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections
US5047407A (en) 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5270315A (en) 1988-04-11 1993-12-14 Biochem Pharma Inc. 4-(purinyl bases)-substituted-1,3-dioxlanes
US4987224A (en) 1988-08-02 1991-01-22 University Of Georgia Research Foundation, Inc. Method of preparation of 2',3'-dideoxynucleosides
DK0674634T3 (da) 1989-02-08 2003-08-04 Iaf Biochem Int Fremgangsmåde til fremstilling af substituerede 1,3-oxathiolaner med antivirale egenskaber
PT95516A (pt) * 1989-10-06 1991-08-14 Wellcome Found Processo para a preparacao de derivados de 2',3'-didesoxi nucleosidos 6-substituidos
US6642245B1 (en) 1990-02-01 2003-11-04 Emory University Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
US5276151A (en) 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US5700937A (en) 1990-02-01 1997-12-23 Emory University Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
JP2960164B2 (ja) 1990-11-13 1999-10-06 バイオケム ファーマ インコーポレイテッド 抗ウイルス特性を有する置換1,3−オキサチオラン類および置換1,3−ジチオラン類
US5179104A (en) 1990-12-05 1993-01-12 University Of Georgia Research Foundation, Inc. Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides
US5444063A (en) 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US5925643A (en) * 1990-12-05 1999-07-20 Emory University Enantiomerically pure β-D-dioxolane-nucleosides
AU9125991A (en) 1990-12-05 1992-07-08 University Of Georgia Research Foundation, Inc., The Enantiomerically pure beta -l-(-)-1,3-oxathiolane nucleosides
IL100965A (en) 1991-02-22 1999-12-31 Univ Emory 2-Hydroxymethyl-5-(5-fluorocytosin-l-yl)-1,3-oxathiolane its resolution and pharmaceutical compositions containing it
WO1992018517A1 (en) 1991-04-17 1992-10-29 Yale University Method of treating or preventing hepatitis b virus
GB9109506D0 (en) 1991-05-02 1991-06-26 Wellcome Found Therapeutic nucleosides
GB9110874D0 (en) 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923641B (en) 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9200150D0 (en) * 1992-01-06 1992-02-26 Wellcome Found Therapeutic nucleosides
US5869461A (en) 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
GB9525606D0 (en) * 1995-12-14 1996-02-14 Iaf Biochem Int Method and compositions for the synthesis of dioxolane nucleosides with › - configuration
US5792773A (en) 1996-11-15 1998-08-11 Yale University L-β-dioxolane uridine analog administration for treating Epstein-Barr virus infection
IL143867A0 (en) * 1998-12-23 2002-04-21 Shire Biochem Inc Antiviral nucleoside analogues

Also Published As

Publication number Publication date
ATE254126T1 (de) 2003-11-15
EP1140937B1 (en) 2003-11-12
NZ513094A (en) 2004-05-28
UY25878A1 (es) 2001-08-27
PT1140937E (pt) 2004-04-30
MXPA01006425A (es) 2002-06-04
CZ20012352A3 (cs) 2001-10-17
IL143867A0 (en) 2002-04-21
US20040058893A1 (en) 2004-03-25
JP2002533470A (ja) 2002-10-08
AU760875B2 (en) 2003-05-22
US20010049372A1 (en) 2001-12-06
EA004767B1 (ru) 2004-08-26
AU1765700A (en) 2000-07-31
NO20013163D0 (no) 2001-06-22
AP2001002207A0 (en) 2001-09-30
EP1140937A2 (en) 2001-10-10
DE69912842D1 (de) 2003-12-18
DE69912842T2 (de) 2004-05-13
NO20013163L (no) 2001-08-20
HUP0104827A2 (en) 2002-06-29
US6358963B1 (en) 2002-03-19
ID30477A (id) 2001-12-13
OA11741A (en) 2005-05-13
CN1334814A (zh) 2002-02-06
EA200100711A1 (ru) 2001-12-24
CA2355712C (en) 2009-03-17
ES2209532T3 (es) 2004-06-16
WO2000039143A2 (en) 2000-07-06
DK1140937T3 (da) 2004-03-22
BR9916849A (pt) 2001-10-30
KR20020013485A (ko) 2002-02-20
CN1117751C (zh) 2003-08-13
TR200102501T2 (tr) 2002-01-21
WO2000039143A3 (en) 2000-11-02
KR100653485B1 (ko) 2006-12-04
HUP0104827A3 (en) 2002-08-28
US6545001B2 (en) 2003-04-08
CA2355712A1 (en) 2000-07-06

Similar Documents

Publication Publication Date Title
US9400280B2 (en) Piperidine derivatives and methods of treating hepatitis B infections
US9126971B2 (en) Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections
US9758489B2 (en) Azepane derivatives and methods of treating hepatitis B infections
ES2244204T3 (es) Derivados de dicetoacidos como inhibidores de polimerasas.
AU2016231615A1 (en) Hepatitis B antiviral agents
CN101983062A (zh) 提高abca-1的化合物及其用途
JP2017504626A (ja) B型肝炎感染症を治療するアゼパン誘導体及び方法
JP2006524711A5 (cg-RX-API-DMAC7.html)
US20040138170A1 (en) Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
CN101132795B (zh) 用于hiv治疗的化合物
WO2016012913A1 (en) Phenyl and tertbutylacetic acid substituted pyridinones having anti-hiv effects
WO1999048371A1 (en) Novel hiv integrase inhibitors and hiv therapy based on drug combinations including integrase inhibitors
AU760875B2 (en) Antiviral nucleoside analogues
EP1382343B1 (en) Combination therapy to treat hepatitis B virus
JP2002533470A5 (cg-RX-API-DMAC7.html)
KR19980701856A (ko) 사람 면역결핍 바이러스 프로테아제 억제제인 인디나비르 및 역전사효소 억제제인 β-L-2',3'-디데옥시-3'-티아사이티딘, 및 임의의 지도부딘, 디데옥시이노신 또는 디데옥시사이티딘을 사용한 사람 면역결핍 바이러스 감염의 배합 치료
JP4887305B2 (ja) Hivの治療に有用な化合物
JPH0352816A (ja) 腎炎の治療剤
JP2008526713A5 (cg-RX-API-DMAC7.html)
JP2014532636A (ja) ウイルス感染の処置のためのヌクレオシドアナログおよび該処置に対する感受性を評価するための方法
US20050049242A1 (en) Novel HIV integrase inhibitors and HIV therapy based on drug combinations including integrase inhibitors
JP7848121B2 (ja) 感冒剤及び抗ウイルス剤
US20040242599A1 (en) Cyclopentene nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
US10844003B1 (en) Dual PPAR-delta and PPAR-gamma agonists
US20230312584A1 (en) Salt of nucleoside analog, and crystal form, pharmaceutical composition and use thereof